Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder.

Authors: Saravanan, K  Schaeren-Wiemers, N  Klein, D  Sandhoff, R  Schwarz, A  Yaghootfam, A  Gieselmann, V  Franken, S 
Citation: Saravanan K, etal., Neurobiol Dis 2004 Jul;16(2):396-406.
Pubmed: (View Article at PubMed) PMID:15193296
DOI: Full-text: DOI:10.1016/j.nbd.2004.03.008

Metachromatic leukodystrophy (MLD) is a lysosomal lipid storage disease caused by arylsulfatase A deficiency. In MLD patients the sphingolipid sulfatide increasingly accumulates leading to progressive demyelination. We have analysed arylsulfatase A-deficient mice, a MLD mouse model, and we show that accumulation of sulfatide is not restricted to the lysosomal compartment but also occurs in myelin itself. Although, this sulfatide storage did not affect the overall composition of most myelin proteins, it specifically caused a severe reduction of MAL. This demonstrates a regulatory link between sulfatide accumulation and MAL expression and indicates the existence of regulatory mechanisms between lipid and myelin protein synthesis in oligodendrocytes. In addition, in cultured renal epithelial cells, sulfatide accumulation diverts MAL to the late endosomal/lysosomal compartment and thus also affects the intracellular distribution of MAL. The specific reduction and mistargeting of MAL protein as a reaction to sulfatide overload may contribute to the pathogenic mechanisms in metachromatic leukodystrophy.


Disease Annotations
Objects Annotated

Additional Information

RGD Object Information
RGD ID: 1358761
Created: 2005-06-27
Species: All species
Last Modified: 2005-06-27
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.